We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
2201
Agenus
AGEN
$290M
$1.1M ﹤0.01%
10,209
+893
+10% +$67K
GRPN icon
2202
Groupon
GRPN
$1.02B
$1.1M ﹤0.01%
25,475
-10,319
-29% -$486K
ONT
2203
Onterris Inc
ONT
$580M
$1.1M ﹤0.01%
20,502
-5,377
-21% -$283K
WOW
2204
DELISTED
WideOpenWest
WOW
$1.1M ﹤0.01%
53,121
-8,354
-14% -$131K
IBCP icon
2205
Independent Bank Corp
IBCP
$844M
$1.1M ﹤0.01%
50,489
-3,911
-7% -$90.3K
DVAX
2206
DELISTED
Dynavax Technologies
DVAX
$1.09M ﹤0.01%
111,108
-17,123
-13% -$156K
HY icon
2207
Hyster-Yale Materials Handling
HY
$665M
$1.09M ﹤0.01%
14,994
-1,678
-10% -$130K
REPL icon
2208
Replimune Group
REPL
$1.01B
$1.09M ﹤0.01%
28,453
+4,835
+20% +$165K
BWIN
2209
Baldwin Insurance Group
BWIN
$2.86B
$1.09M ﹤0.01%
40,962
-1,640
-4% -$44.5K
MRSN
2210
DELISTED
Mersana Therapeutics
MRSN
$1.09M ﹤0.01%
3,213
+498
+18% +$189K
TG icon
2211
Tredegar Corp
TG
$310M
$1.09M ﹤0.01%
78,994
-12,422
-14% -$187K
IDT icon
2212
IDT Corp
IDT
$1.62B
$1.08M ﹤0.01%
29,347
+5,573
+23% +$158K
CCXI
2213
DELISTED
ChemoCentryx, Inc.
CCXI
$1.08M ﹤0.01%
80,459
+21,052
+35% +$519K
ATEC icon
2214
Alphatec Holdings
ATEC
$1.44B
$1.07M ﹤0.01%
70,079
+9,974
+17% +$154K
LUNG icon
2215
Pulmonx
LUNG
$87.6M
$1.07M ﹤0.01%
24,343
+11,788
+94% +$513K
SWI
2216
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.07M ﹤0.01%
60,292
+16,012
+36% +$290K
DRVN icon
2217
Driven Brands
DRVN
$2.2B
$1.07M ﹤0.01%
34,464
+4,320
+14% +$122K
MGI
2218
DELISTED
MoneyGram International, Inc. New
MGI
$1.07M ﹤0.01%
105,758
+18,966
+22% +$160K
FMTX
2219
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1.06M ﹤0.01%
42,516
+11,176
+36% +$300K
QADA
2220
DELISTED
QAD Inc.
QADA
$1.05M ﹤0.01%
12,127
-712
-6% -$52K
HBNC icon
2221
Horizon Bancorp
HBNC
$1.04B
$1.05M ﹤0.01%
60,475
-7,145
-11% -$130K
FRGI
2222
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$1.05M ﹤0.01%
78,386
-3,332
-4% -$45.4K
CCO icon
2223
Clear Channel Outdoor Holdings
CCO
$1.23B
$1.05M ﹤0.01%
+398,345
New +$955K
CLBK icon
2224
Columbia Financial
CLBK
$1.13B
$1.05M ﹤0.01%
60,969
-14,268
-19% -$251K
ECVT icon
2225
Ecovyst
ECVT
$1.14B
$1.05M ﹤0.01%
68,372
+7,738
+13% +$122K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.